Latest News and Press Releases
Want to stay updated on the latest news?
-
Serotonin Centers opens in Fort Worth, bringing physician-led longevity care, hormone optimization and medical weight loss to North Texas.
-
GCLS launches the world’s first PhD in Longevity Sciences, integrating aging biology into structured medical doctoral research.
-
GB HealthWatch launches an AI-ready genetic report for its GB Longevity100 suite, delivering actionable insights for longevity and disease prevention
-
SupplySide Connect New Jersey gathered professionals from manufacturers, suppliers and retailers to drive the ingredient manufacturing industry forward
-
OCEANSIDE, Calif. and SOMERSET, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- via IBN -- EDERRA today announced it has entered into a Letter of Intent (LOI), dated March 26, 2026, with Cepham for a...
-
New Home Offerings Pair Performance-driven, Architecturally Significant Design with Longevity-Science and Personalized Testing LAS VEGAS, March 19, 2026 (GLOBE NEWSWIRE) -- Blue Heron, the...
-
Serotonin Centers launches a Partner Program bringing longevity services into gyms, helping improve member results, increase retention & generate revenue.
-
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology company developing therapies for the treatment of neurodegenerative and aging-related diseases, today announced...
-
Oxford Healthspan announces that its longevity supplement Primeadine® GF has been named a 2026 NEXTY Awards Finalist.
-
PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic diseaseCarmel Nanthakumar,...